Foetal testosterone and autistic traits in 18 to 24-month-old children by Auyeung, Bonnie et al.
Auyeung et al. Molecular Autism 2010, 1:11
http://www.molecularautism.com/content/1/1/11
Open AccessR E S E A R C HResearchFoetal testosterone and autistic traits in 18 to 
24-month-old children
Bonnie Auyeung*1, Kevin Taylor2, Gerald Hackett3 and Simon Baron-Cohen1
Abstract
Background: Autism spectrum conditions have been characterised as an extreme presentation of certain male-typical 
psychological traits. In addition, several studies have established a link between prenatal exposure to testosterone and 
cognitive sex differences in later life, and one study found that foetal testosterone (FT) is positively correlated to autistic 
traits in 6 to 10 year-old children. In this study, we tested whether FT is positively correlated with autistic traits in 
toddlers aged 18-24 months.
Methods: Levels of FT were analysed in amniotic fluid and compared with autistic traits, measured using the 
Quantitative Checklist for Autism in Toddlers (Q-CHAT) in 129 typically developing toddlers aged between 18 and 24 
months (mean ± SD 19.25 ± 1.52 months).
Results: Sex differences were observed in Q-CHAT scores, with boys scoring significantly higher (indicating more 
autistic traits) than girls. In addition, we confirmed a significant positive relationship between FT levels and autistic 
traits.
Conclusions: The current findings in children between 18 and 24 months of age are consistent with observations in 
older children showing a positive association between elevated FT levels and autistic traits. Given that sex steroid-
related gene variations are associated with autistic traits in adults, this new finding suggests that the brain basis of 
autistic traits may reflect individual differences in prenatal androgens and androgen-related genes. The consistency of 
findings in early childhood, later childhood and adulthood suggests that this is a robust association.
Background
Autism, high-functioning autism, Asperger syndrome
(AS) and pervasive developmental disorder not otherwise
specified (PDD-NOS) are collectively referred to as
autism spectrum conditions (ASC). Recent research has
suggested that ASC represent the upper extreme of a col-
lection of traits that are continuously distributed in the
population [1,2]. This continuum view provides a shift
away from the categorical diagnostic approach and
towards a quantitative approach for measuring autistic
traits.
The strong bias of ASC towards males is well estab-
lished [3], with a clear male to female ratio, estimated at
4:1 for classic autism [4] and as high as 10.8:1 in individu-
als with AS [5]. The extreme male brain (EMB) theory of
autism proposes that ASC are an exaggeration of certain
male-typical traits [6,7]. This theory has been extended to
explain both cognition and neuroanatomy in individuals
with autism [8]. It has been suggested that prenatal expo-
sure to testosterone may be a key biological mechanism
for shaping sex differences in the brain, and may be
involved in the biased sex ratio found in these conditions
[8,9].
Although genetic sex is determined at conception, it is
the gonadal hormones (that is, androgens, estrogens and
progestins) that are responsible for differentiation of the
male and female phenotypes in the developing human
foetus [10]. Direct sampling of foetal serum or manipula-
tion of foetal hormone levels would be very dangerous;
hence, researchers have used indirect methods of mea-
suring prenatal hormone exposure to study effects on
later development.
One such indirect measure is the ratio between the
length of the second and fourth digits (2D:4D) of the
hand. This ratio has been found to be sexually dimorphic,
being lower in males than in females. The 2D:4D ratio is
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Page 2 of 8thought to be fixed by week 14 of foetal life, and has been
found to reflect foetal exposure to prenatal sex hormones
in early gestation [11,12]. Results from studies of 2D:4D
ratios as a proxy for FT levels show that children with
ASC have more masculinised digit ratios compared with
typically developing boys. These patterns have also been
observed in the siblings and parents of children with
ASC, indicating the possibility of a link between geneti-
cally based elevated FT levels and the development of
ASC [13,14]. Other evidence of a genetic link to ASC was
provided by a recent study, which showed that genes reg-
ulating sex steroids are associated with autistic traits, as
measured by scores on the Autism Spectrum Quotient
(AQ), in a typical adult sample [15]. A parallel study also
showed that genes regulating sex steroids are associated
with a diagnosis of AS in a case-control sample [15].
The medical condition of congenital adrenal hyperpla-
sia (CAH) leads to abnormally high androgen levels, and
has provided researchers with a 'natural experiment' in
which to examine the effects of elevated androgen expo-
sure. Girls with CAH have more autistic traits (measured
using the adult AQ) than their unaffected sisters [16].
Given that this condition is usually treated after birth,
this suggests that the higher AQ scores in such children
reflect elevated prenatal androgen levels. However, these
findings should be interpreted with caution, because
CAH carries a number of related problems (and requires
extensive treatment) which may affect the atypical cogni-
tive profiles found in this population [17,18].
Some studies have also compared measurements of tes-
tosterone in umbilical cord (UC) blood with postnatal
development. A recent study using UC blood testoster-
one measurements examined pragmatic language ability
in girls followed up at 10 years of age. Results showed that
the higher a girl's free testosterone level at birth, the
higher the scores on a pragmatic language difficulties
questionnaire [19]. However, levels of FT are typically at
very low levels from about week 24 of gestation, and UC
samples can contain blood from the mother as well as the
foetus (and hormone levels may vary due to labour itself )
[20], so UC blood testosterone does not allow testing of
whether outcomes reflect FT per se.
Currently, the best method to examine the effect of FT
is to sample via amniocentesis the amniotic fluid sur-
rounding the foetus. An advantage of amniotic fluid sam-
ples is that amniocentesis is often performed for routine
clinical purposes within a relatively narrow time period
that coincides with the hypothesised critical period for
human sexual differentiation between weeks 8 and 24 of
gestation [21]. This is also more direct than the 2D: 4D
method, as the hormones themselves can be assayed,
rather than relying on a proxy for these.
Several studies have linked elevated levels of FT in the
amniotic fluid with the masculinisation of certain behav-
iours, beginning shortly after birth. Elevated FT has been
linked to reduced eye contact in infants, smaller vocabu-
lary in toddlers, narrower interests at 4 years of age, less
empathy at 4 and 8 years, and increased systemizing (the
drive to analyse and construct systems) at 8 years [9,22-
26]. In addition, FT levels have been found to be posi-
tively correlated with the number of autistic traits in
older children (6-10 years old), using two independent
dimensional measures of autistic traits (the AQ-Child
version and the Childhood Autism Spectrum Test) [27].
The current study aimed to extend our understanding
of the effect of prenatal hormones on the development of
autistic traits, using a new measure for evaluating autistic
traits in toddlers. The Quantitative Checklist for Autism
in Toddlers (Q-CHAT) is a parent-report questionnaire
that evaluates autistic traits in toddlers between 18 and
24 months old [28]. Scores on this measure have shown a
near-normal distribution in a large general population
sample (n = 779), suggesting that it is a useful measure of
individual differences in autistic traits in toddlers [28]. In
the present study, the relationship between measure-
ments of FT and scores on the Q-CHAT were examined.
Methods
This study was given ethical approval by the National
Health Service Suffolk Research Ethics Committee. Writ-
ten informed consent was obtained from general practi-
tioners (GPs) and participating parents.
Participants
Mothers were asked to participate in research at the time
of having an amniocentesis (between 2004 and 2006).
The medical records of approximately 700 amniocentesis
patients were examined, and participants were excluded
if: (1) there was a twin pregnancy; (2) amniocentesis
revealed chromosomal abnormality; (3) the child suffered
significant medical problems after birth or (4) records
were incomplete. Women whose GP gave consent (n =
283) were contacted for participation. The final sample
for this study included 129 participants (66 boys, 63 girls)
with complete data.
Outcome variable
The outcome variable was the Q-CHAT. This is a 25-item
parent-report screening measure developed to identify
toddlers at risk for development of ASC. This measure is
a major revision of the Checklist for Autism in Toddlers
(CHAT) which was a screening tool originally developed
for use by health professionals for children aged between
18 and 24 months. Instead of using a binary (yes/no) for-
mat, the Q-CHAT uses a five-point scale of frequency of
behaviour to allow a greater range of responses. The
items of the Q-CHAT aim to measure areas of toddler
development including joint attention (e.g., gaze-follow-
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pretend play, language development, repetitive behav-
iours, and social communication. A total score is
obtained with a minimum score of 0 and a maximum
score of 100 [28]. The instrument was designed to have a
broad range to best capture the dimensional nature of
autistic traits in a general population.
Predictor variable
The predictor variable was FT level. FT was measured
from amniotic fluid by radioimmunoassay (at Depart-
ment of Clinical Biochemistry, Addenbrooke's Hospital,
Cambridge, UK) using a method that has been reported
previously [24,27]. Amniotic fluid was extracted with
diethyl ether. The ether was evaporated to dryness at
room temperature, and the extracted material redissolved
in an assay buffer. Testosterone was measured by a com-
mercial assay ('Count-a-Coat'; Diagnostic Products Corp,
Los Angeles, CA, USA), which uses an antibody to testos-
terone coated onto propylene tubes and a 125-I labelled
testosterone analogue. FT level is expressed as nmol/L.
The detection limit of the assay using the ether-extrac-
tion method is approximately 0.05 nmol/L. The coeffi-
cient of variation (CV) for between-batch imprecision is
19% at a concentration of 0.8 nmol/L, and 9.5% at a con-
centration of 7.3 nmol/L. CVs for within-batch impreci-
sion are 15% at a concentration of 0.3 nmol/L, and 5.9% at
a concentration of 2.5 nmol/L. This method measures
total extractable testosterone.
Control variables
Foetal estradiol (FE) levels
In rodents, conversion of FT to FE in the brain has been
shown to be one mechanism for masculinisation of
behaviour [29,30]. The role of estradiol in human devel-
opment is unclear, and it has been suggested that testos-
terone directly influences sexual differentiation without
being converted [31,32]. Measurements of FE therefore
were included as a control variable to further examine
whether there were any relationships with the other vari-
ables.
Gestational age at amniocentesis (in weeks)
Amniotic fluid samples were collected between weeks 11
and 21 of gestation (mean ± SD 16.92 ± 1.83). This timing
coincides with the hypothesised critical period for human
sexual differentiation (between approximately weeks 8
and 24 of gestation [9,21]).
Maternal age
Maternal age was included because women undergoing
amniocentesis have a higher mean age than the general
childbearing population.
Level of education obtained by parents
The mean maternal and paternal education level was
computed. Parental education level was measured
according to a five-point scale (1 = no formal qualifica-
tions, 2 = O level/General Certificate of Secondary Edu-
cation (GCSE) or equivalent, 3 = A-level, Higher National
Diploma (HND) or vocational qualification, 4 = univer-
sity degree and 5 = postgraduate qualification).
Presence of older siblings
Older siblings have been found in previous research to
have an effect on the social environment and influence
child development [33]. This variable was defined as
older brothers present in the home (or not) and older sis-
ters present in the home (or not).
Child's age
The children included in the analyses were between 18
and 24 months of age (19.25 ± 1.52) at the time of Q-
CHAT administration. Age was also included as a control
variable.
Results
FT levels
Three male outliers in FT levels (individuals who scored 3
SDs above the mean) were observed. A winsorizing pro-
cedure was used [34], in which the extreme values were
replaced by the highest observed level within 3SD from
the mean (1.55 nmol/L). No outliers were found when FT
levels were examined in girls. Winsorized FT levels
showed no outliers and acceptable skewness statistics for
both boys and girls, and were used in subsequent analy-
ses. Independent samples t-tests showed significant sex
differences in winsorized FT levels t(110.93) = 8.71, P <
0.001 (equal variances not assumed), with boys (0.80 ±
0.36) showing higher levels than girls (0.34 ± 0.23).
Control variables
Examination of the univariate distributions of the control
variables showed that levels of FE were positively skewed
(skewness > 1) so a natural logarithmic transformation
was carried out. This reduced the skewness to < 1, and
transformed FE data were used in subsequent analyses.
No sex differences were observed in transformed FE lev-
els (t(127) = 0.22, P > 0.05). All other control variables
showed acceptable distributions, with no outliers and no
sex differences (all P > 0.05).
Q-CHAT scores
Examination of the univariate distribution of Q-CHAT
scores revealed that it was not significantly skewed
(skewness < 1) for all cases together, or for boys and girls
separately, thus the raw scores were used in further analy-
ses. Figure 1 shows the distribution of Q-CHAT scores.
Scores on the Q-CHAT showed significant sex differ-
ences (t(127) = 2.59, P = 0.01; equal variances assumed),
with boys (28.09 ± 7.30) scoring higher than girls (24.94 ±
6.52) (see Table 1 for descriptive information and Q-
CHAT score correlations with FT and the control vari-
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Table 1: Descriptive information and correlations with Quantitative Checklist for Autism in Toddlers (Q-CHAT) scores
Combined group Girls Boys Sex difference 
effect size (d)
Variable n Mean SD Range r n Mean SD Range r n Mean SD Range r
FT levela, nmol/Lc 129 0.59 0.41 0.05 to 2.28 0.40** 63 0.34 0.27 0.05 to 1.12 0.31* 66 0.82 0.42 0.15 to 2.28 0.36* 1.36
FE levela, pmol/L 129 307.12 186.29 108 to 1260 0.01 63 309.67 181.98 126 to 1260 0.06 66 304.70 191.68 108 to 1220 -0.01 0.03
Gestational age 120 16.92 1.83 13 to 26 -0.13 60 17.01 1.62 15 to 22.3 0.06 60 16.83 2.03 13 to 26 -0.25 0.10
Child age 129 19.25 1.52 18 to 24 -0.15 63 19.40 1.50 18 to 23 0.08 66 19.11 1.53 18 to 24 -0.19 0.19
Maternal age 129 35.67 4.21 21 to 46 0.06 63 35.81 4.26 24 to 46 -0.01 66 35.53 4.18 21 to 45 0.14 0.07
Parental education 127 3.56 1.05 1 to 5 -0.02 61 3.58 1.05 1 to 5 0.12 66 3.54 1.06 1 to 5 -0.13 0.04
Q-CHAT Scoreb 129 26.55 7.08 10 to 43 - 63 24.94 6.52 10 to 43 - 66 28.09 7.30 14 to 43 - 0.46
aIndicates raw values.
bSex difference is significant at the P < 0.05 level.
cSex difference is significant at the P < 0.01 level.
r = correlation value between each variable and Q-CHAT scores.
* P < 0.05 level
** P < 0.01 level
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using 'Cohen's d'. A 'd' value of 0.2 is considered a small
effect size; a 'd' of 0.5, a medium effect size; and a 'd' > 0.8,
a large effect size [35].
Data were examined using a hierarchical multiple
regression analysis to determine potential predictors of
Q-CHAT scores. In the first stage, any predictor variable
showing a significant correlation with the outcome at the
P < 0.20 was entered into the analysis [36]. The only vari-
able meeting this criteria was gestational age (r = -0.13, P
< 0.20), which was included in the first stage using the
enter method. FT level (r = 0.40, P < 0.001) and sex (r =
0.22, P < 0.05) were tested for entry in the second stage
using the stepwise method. The sex and FT level interac-
tion (sex/FT interaction) was also tested for inclusion in
the third stage using the stepwise method. The second
stage retained FT levels (F change = 22.78, P < 0.001, ΔR2
= 0.16), whereas sex and the sex/FT interaction were
excluded from the final model (Figure 2).
Within-sex analyses showed that for girls, no variables
met the criteria for entry into the hierarchical regression
analyses except for FT level (r = 0.31, P < 0.05). This was
entered in the first stage using the stepwise method. FT
level was retained and produced a significant F change (F
change = 6.59, P < 0.05, ΔR2 = 0.10). For boys, gestational
age (r = -0.25, P < 0.20) and child age (r = -0.19, P < 0.20)
were entered in the first stage of the regression analysis.
Inclusion of FT level in the second stage also produced a
significant F change (F change = 9.60, P < 0.01, ΔR2 =
0.14) (see Table 2).
Discussion
This study examined the relationships between amniotic
measurements of FT and autistic traits measured using
the Q-CHAT. Sex differences were observed, with boys
scoring higher on the Q-CHAT than girls. These early sex
differences are consistent with other studies in young
children that have found a female advantage in eye con-
tact [26], vocabulary development [25] and preference for
looking at faces [37,38]. They are also consistent with sex
differences on measures of autistic traits, both on the
Childhood Autism Spectrum Test [39], the Autism Spec-
trum Quotient (AQ)-Child version [40], the AQ-Adoles-
cent version [41] and on the English version of the adult
AQ [1]. This pattern has also been observed cross-cultur-
ally using translated versions of the AQ [42-45].
FT levels were found to be approximately 2.5 times
higher in boys than girls, consistent with previous studies
using measurements of testosterone levels in amniotic
fluid [22,23,27,46-48]. FT level was the only variable that
was significantly related to Q-CHAT scores, both when
the sexes were combined and when girls and boys were
examined separately. Sex and the sex/FT interaction were
not retained in the final regression model, suggesting that
this is an effect of FT, rather than sex. No significant asso-
ciation between FT levels and FE levels was found, nor
was FE correlated with autistic traits, and nor was there
any association between child sex and FE levels (r = -0.02,
P > 0.05), providing evidence for a link between autistic
traits and FT levels rather than FE levels. This replicates
previous studies showing no link between FE levels and
behaviour [24-26,49,50].
The current study supports the idea that FT levels are
associated with autistic traits in toddlers. Like previous
research in older children showing a positive relationship
with FT levels and autistic traits in 6 to 10-year-olds [27],
these results at 18 to 24 months of age suggest that FT
levels are associated with aspects of early development
measured by the Q-CHAT, including sociability, early
play behaviour and joint attention. These findings across
different ages in development also suggest that the asso-
ciation between FT and autistic traits is robust. However,
owing to the correlational design of this study, these
Figure 2 Relationship between foetal testosterone (FT) level and 
Quantitative Checklist for Autism in Toddlers (Q-CHAT) scores.
Figure 1 Distribution of Quantitative Checklist for Autism in Tod-
dlers (Q-CHAT) scores.
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of autism. Causality can only be demonstrated by manip-
ulation of FT levels, which in humans would be wholly
unethical. In addition, these studies only provide evi-
dence for the role of FT in the development of autistic
traits in typically developing children. This association
remains to be tested in clinical samples, and a large-scale
collaboration is currently underway to obtain a sufficient
sample size to compare FT levels in cases of ASC versus
controls.
The majority of total circulating testosterone is bound
to sex hormone-binding globulin, and to albumin- and
cortisol-binding globulin, and only the remaining 1-2%
(the free fraction) is active [51]. In this study, the assay
used can only measure total extractable testosterone and
cannot be adapted to obtain measurements of free frac-
tion testosterone levels. Whitehouse et al. (in press)
obtained measurements of both the total testosterone
and the free fraction testosterone concentrations using
UC blood samples, and investigated relationships to prag-
matic language ability in girls [19]. Although the only sig-
nificant relationship was observed between the free
fraction testosterone and pragmatic language ability, a
significant correlation was also observed between total
testosterone and the free fraction testosterone concentra-
tions (r = 0.64, P < 0.01). This suggests that the measure-
ments of total testosterone obtained in this study are still
useful.
It is also known that hormones fluctuate during the day
and between days, even in foetuses [52,53]. It is not possi-
ble to obtain repeated samples of FT because amniocen-
tesis itself carries a risk of causing miscarriage (of about
1%) [54,55] so obtaining amniotic FT measures are
opportunistic, when the procedure is being carried out
for clinical reasons, with never more than a single mea-
surement of FT at one time-point. The representative-
ness of a single sample of FT thus remains unclear, but
would be difficult to explore in an ethical manner. Given
the reported time course of testosterone secretion [56],
the most promising time to measure FT is probably at
prenatal weeks 8 to 24 [9,21,57], but this is still a relatively
wide range. The inferences we can therefore draw about
the single measurement of FT are necessarily limited.
This sample of children whose mothers had undergone
amniocentesis is also not representative of the wider pop-
ulation (for example, maternal age is usually higher in
such samples). In this study, no relationship between
maternal age and Q-CHAT scores were observed, sug-
gesting that the association found here may apply to all
pregnant women. For the reasons mentioned above, it
would be unethical to test this association in a randomly
selected sample of the child-bearing population [9].
Conclusions
We conclude that autistic traits are already sexually
dimorphic as young as 18 months of age, and that FT is a
significant predictor of autistic traits. The current find-
ings are consistent with results in older (6 to 10 year-old)
children, which have also shown that FT levels are a sig-
nificant predictor of autistic traits. These results point to
the importance of looking at factors that are involved
with FT levels (such as genetic polymorphisms [15]) to
understand the ultimate causes of individual variation in
number of autistic traits.
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Table 2: Final regression model for quantitative checklist for autism in toddlers (Q-CHAT) scores
Outcome Predictors Final regression model
R2 Δ R2 B SE β P
Group
Q-CHAT Score Gestational age 0.02 0.02 0.47 0.32 0.12 > 0.05
FT level 0.18 0.16 7.32 1.53 0.4 < 0.001
Girls only
Q-CHAT Score FT level 0.1 0.1 8.97 3.5 0.31 < 0.05
Boys only
Q-CHAT Score Gestational age 0.07 0.07 0.75 0.43 0.21 > 0.05
Child age 0.1 0.57 0.02 > 0.05
FT level 0.21 0.14 7.36 2.38 0.37 < 0.01
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